糖尿病性足潰瘍治療市場：治療法、潰瘍タイプ、最終用途別-2025-2030年の世界予測

糖尿病性足潰瘍治療市場の2023年の市場規模は53億5,000万米ドルで、2024年には56億9,000万米ドルに達すると予測され、CAGR 6.56％で成長し、2030年には83億5,000万米ドルに達すると予測されています。

糖尿病性足潰瘍治療市場には、糖尿病患者の足潰瘍の管理と治癒を目的とした幅広い製品とサービスが含まれます。これには、ドレッシング材、移植片、陰圧創傷治療などの高度創傷ケアソリューションと、プロテアーゼ阻害剤や抗生物質治療などの医薬品が含まれます。これらの治療が必要とされる背景には、世界の糖尿病罹患率の増加があります。糖尿病は血行不良や神経障害により足潰瘍のリスクを高め、治療しなければ重症感染症や切断の可能性があります。用途は病院やクリニックから在宅医療まで幅広く、最終用途は主に医療機関や患者個人です。成長に影響を与える主な要因としては、創傷治療技術の進歩、糖尿病合併症の深刻さに対する患者の意識の高まり、糖尿病治療の改善に向けた政府の取り組みなどが挙げられます。ビジネスチャンスとしては、個別化医療へのアプローチや、潰瘍の遠隔モニタリングと管理のためのAIとIoTの統合が挙げられます。推奨事項としては、生分解性および生体工学的創傷ケア製品の研究開発への投資、技術統合のためのパートナーシップの模索などが挙げられます。しかし、市場の成長は、特に低所得地域における高い治療費や熟練したヘルスケア専門家の不足といった課題に直面しています。規制上の障壁や償還の問題が市場力学をさらに複雑にしています。技術革新のチャンスは、患者のコンプライアンスを向上させる遠隔医療プラットフォームと、新興諸国でのアクセスを拡大するための費用対効果の高いソリューション開発にあります。市場は競合的に細分化されている一方で協調的であり、絶え間ない技術の進歩と、専門知識を共有するための主要企業間の戦略的提携が特徴です。特に、イノベーションを奨励し、市場参入の障壁を軽減する政策的枠組みによって支援されれば、有効性と手頃な価格のバランスを備えた患者中心のソリューションに焦点を当てることで、持続的な成長を促進することができます。

市場力学：急速に進化する糖尿病性足潰瘍治療市場の主要市場インサイトを公開

糖尿病性足潰瘍治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 高齢者人口における糖尿病性足潰瘍の有病率の増加
  • ヘルスケア専門家における効果的なDPU管理に関する意識の高まり
• 市場抑制要因
  • 高度な創傷治療機器や治療法の高コスト
• 市場機会
  • 積極的な糖尿病性足潰瘍治療薬の新規導入の継続
  • 糖尿病性足潰瘍予防のための費用対効果の高いソリューションの開発拡大
• 市場の課題
  • 糖尿病性足潰瘍に対する償還政策が限られていること

ポーターのファイブフォース：糖尿病性足潰瘍治療市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：糖尿病性足潰瘍治療市場における外部からの影響の把握

外部マクロ環境要因は、糖尿病性足潰瘍治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析糖尿病性足潰瘍治療市場における競合情勢の把握

糖尿病性足潰瘍治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス糖尿病性足潰瘍治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、糖尿病性足潰瘍治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨糖尿病性足潰瘍治療市場における成功への道筋を描く

糖尿病性足潰瘍治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢者における糖尿病性足潰瘍の罹患率が増加
    • ヘルスケア従事者の間で効果的なDPU管理に関する意識が高まっている
  • 抑制要因
    • 高度な創傷治療機器と治療法の高コスト
  • 機会
    • 糖尿病性足潰瘍に対する新たな治療法のイントロダクションが進行中
    • 糖尿病性足潰瘍予防のための費用対効果の高いソリューションの開発が進む
  • 課題
    • 糖尿病性足潰瘍に対する償還ポリシーの利用可能性は限られている
• 市場セグメンテーション分析
  • 治療：創傷ケア用ドレッシングと治療機器の革新により、ケアを最適化し、患者の転帰を改善します。
  • 最終用途：低コストで高度なDFU治療を病院全体で利用できるように拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 糖尿病性足潰瘍治療市場治療別

• 抗生物質
• 生物学的製剤
  • 成長因子
  • 皮膚移植
• 治療機器
  • 陰圧閉鎖療法
  • 超音波療法
• 創傷ケア用ドレッシング
  • アルギン酸塩ドレッシング
  • フィルムドレッシング
  • フォームドレッシング
  • ハイドロコロイドドレッシング
  • ハイドロファイバードレッシング
  • ハイドロゲルドレッシング
  • 外科用包帯

第7章 糖尿病性足潰瘍治療市場潰瘍の種類別

• 虚血性潰瘍
• 神経虚血性潰瘍
• 神経障害性潰瘍

第8章 糖尿病性足潰瘍治療市場：最終用途別

• 外来画像診断センター
• 病院

第9章 南北アメリカの糖尿病性足潰瘍治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の糖尿病性足潰瘍治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの糖尿病性足潰瘍治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 研究者らが糖尿病性足潰瘍の革新的な治療となる3Dプリント包帯を開発
  • Healthiumが糖尿病性足潰瘍治療薬Theruptor Novoを発売
  • スミス・ネフュー社は、GRAFIXメンブレンが競合製品と比較して糖尿病性足潰瘍の再発率を半分に削減したことを示す新たな研究を発表しました。
  • アルケム・ラボラトリーズ、糖尿病性足潰瘍管理技術の発売を発表
• 戦略分析と提言

企業一覧

• 3M Company
• Adocia SA
• Alkem Laboratories Ltd.
• B. Braun SE
• Cardinal Health, Inc.
• Centaur Pharmaceuticals Private Limited
• Cipla Limited
• Coloplast Corp.
• ConvaTec, Inc.
• Essity AB
• GlaxoSmithKline PLC
• Healthium Medtech Limited
• Integra LifeSciences Corporation
• Medline Industries, Inc.
• MIMEDX, Inc.
• Molnlycke Health Care AB
• Organogenesis, Inc.
• PAUL HARTMANN AG
• Pristyn Care
• Reapplix A/S
• SANUWAVE Health, Inc.
• SIGVARIS Group
• Smith & Nephew PLC
• SynerHeal Pharmaceuticals
• Tissue Regenix Ltd.
• URGO Medical, Australia Pty Ltd.

LIST OF FIGURES

• FIGURE 1. DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DIABETIC FOOT ULCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DIABETIC FOOT ULCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DIABETIC FOOT ULCER TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DIABETIC FOOT ULCER TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ANTIBIOTIC MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY SKIN GRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY NEGATIVE PRESSURE WOUND THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULTRASOUND THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ALGINATE DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY FILM DRESSING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY FOAM DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY HYDROCOLLOID DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY HYDROFIBER DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY HYDROGEL DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY SURGICAL DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ISCHEMIC ULCERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY NEURO-ISCHEMIC ULCERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY NEUROPATHIC ULCERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY AMBULATORY IMAGING CENTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 53. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 54. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 55. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 56. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 57. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 84. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 85. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 86. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 87. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 88. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 89. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 90. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 91. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 92. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 93. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 94. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 95. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 193. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 194. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 195. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 196. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 197. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 198. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 217. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 218. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 219. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 220. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 221. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 222. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 223. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 224. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 225. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 226. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 227. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 228. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 283. DIABETIC FOOT ULCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 284. DIABETIC FOOT ULCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Diabetic Foot Ulcer Treatment Market was valued at USD 5.35 billion in 2023, expected to reach USD 5.69 billion in 2024, and is projected to grow at a CAGR of 6.56%, to USD 8.35 billion by 2030.

The diabetic foot ulcer treatment market encompasses a broad range of products and services aimed at managing and healing foot ulcers in diabetic patients. This includes both advanced wound care solutions such as dressings, grafts, and negative pressure wound therapy, as well as pharmaceuticals like protease inhibitors and antibiotic treatments. The necessity for these treatments arises from the increasing global prevalence of diabetes, which heightens the risk of foot ulcers due to poor circulation and neuropathy, leading to the potential for severe infections and amputations if untreated. Applications span from hospital and in-clinic environments to home healthcare settings, with end-use primarily involving healthcare institutions and individual patients. Key factors influencing growth include advancements in wound care technologies, rising awareness among patients regarding the severity of diabetic complications, and government initiatives to improve diabetic care. On the opportunity front, the market offers potential in personalized medicine approaches and the integration of AI and IoT for remote monitoring and management of ulcers. Recommendations include investing in R&D for biodegradable and bioengineered wound care products and exploring partnerships for technology integration. However, market growth faces challenges such as high treatment costs, particularly in low-income regions, and the lack of skilled healthcare professionals. Regulatory barriers and reimbursement issues further complicate market dynamics. Innovation opportunities lie in telemedicine platforms for better patient compliance and developing cost-effective solutions to expand access in developing countries. The market is competitively fragmented yet collaborative, characterized by constant technological advancements and strategic alliances among key players to leverage shared expertise. Focus on patient-centric solutions that balance effectiveness with affordability can drive sustained growth, particularly if supported by policy frameworks that encourage innovation and reduce barriers to market entry.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diabetic Foot Ulcer Treatment Market

The Diabetic Foot Ulcer Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of diabetic foot ulcers among the geriatric population
  • Rising awareness about effective DPU management among healthcare professionals
• Market Restraints
  • High cost of advanced wound care devices and therapies
• Market Opportunities
  • Ongoing introduction of new active diabetic foot ulcer therapies
  • Growing development of cost-effective solutions for diabetic foot ulcer prevention
• Market Challenges
  • Limited availability of reimbursement policies for diabetic foot ulcers

Porter's Five Forces: A Strategic Tool for Navigating the Diabetic Foot Ulcer Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diabetic Foot Ulcer Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diabetic Foot Ulcer Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diabetic Foot Ulcer Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diabetic Foot Ulcer Treatment Market

A detailed market share analysis in the Diabetic Foot Ulcer Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diabetic Foot Ulcer Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diabetic Foot Ulcer Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diabetic Foot Ulcer Treatment Market

A strategic analysis of the Diabetic Foot Ulcer Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diabetic Foot Ulcer Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Adocia SA, Alkem Laboratories Ltd., B. Braun SE, Cardinal Health, Inc., Centaur Pharmaceuticals Private Limited, Cipla Limited, Coloplast Corp., ConvaTec, Inc., Essity AB, GlaxoSmithKline PLC, Healthium Medtech Limited, Integra LifeSciences Corporation, Medline Industries, Inc., MIMEDX, Inc., Molnlycke Health Care AB, Organogenesis, Inc., PAUL HARTMANN AG, Pristyn Care, Reapplix A/S, SANUWAVE Health, Inc., SIGVARIS Group, Smith & Nephew PLC, SynerHeal Pharmaceuticals, Tissue Regenix Ltd., and URGO Medical, Australia Pty Ltd..

Market Segmentation & Coverage

This research report categorizes the Diabetic Foot Ulcer Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Treatment, market is studied across Antibiotic Medications, Biologics, Therapy Devices, and Wound Care Dressings. The Biologics is further studied across Growth Factors and Skin Grafts. The Therapy Devices is further studied across Negative Pressure Wound Therapy and Ultrasound Therapy. The Wound Care Dressings is further studied across Alginate Dressings, Film Dressing, Foam Dressings, Hydrocolloid Dressings, Hydrofiber Dressings, Hydrogel Dressings, and Surgical Dressings.
• Based on Ulcer Type, market is studied across Ischemic Ulcers, Neuro-Ischemic Ulcers, and Neuropathic Ulcers.
• Based on End-use, market is studied across Ambulatory Imaging Center and Hospital.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of diabetic foot ulcers among the geriatric population
    • 5.1.1.2. Rising awareness about effective DPU management among healthcare professionals
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of advanced wound care devices and therapies
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing introduction of new active diabetic foot ulcer therapies
    • 5.1.3.2. Growing development of cost-effective solutions for diabetic foot ulcer prevention
  • 5.1.4. Challenges
    • 5.1.4.1. Limited availability of reimbursement policies for diabetic foot ulcers
• 5.2. Market Segmentation Analysis
  • 5.2.1. Treatment: Innovations in wound care dressings and therapy devices to optimize care and improve patient outcomes
  • 5.2.2. End-Use: Expanding availability of low-cost and advanced DFU treatments across hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Diabetic Foot Ulcer Treatment Market, by Treatment

• 6.1. Introduction
• 6.2. Antibiotic Medications
• 6.3. Biologics
  • 6.3.1. Growth Factors
  • 6.3.2. Skin Grafts
• 6.4. Therapy Devices
  • 6.4.1. Negative Pressure Wound Therapy
  • 6.4.2. Ultrasound Therapy
• 6.5. Wound Care Dressings
  • 6.5.1. Alginate Dressings
  • 6.5.2. Film Dressing
  • 6.5.3. Foam Dressings
  • 6.5.4. Hydrocolloid Dressings
  • 6.5.5. Hydrofiber Dressings
  • 6.5.6. Hydrogel Dressings
  • 6.5.7. Surgical Dressings

7. Diabetic Foot Ulcer Treatment Market, by Ulcer Type

• 7.1. Introduction
• 7.2. Ischemic Ulcers
• 7.3. Neuro-Ischemic Ulcers
• 7.4. Neuropathic Ulcers

8. Diabetic Foot Ulcer Treatment Market, by End-use

• 8.1. Introduction
• 8.2. Ambulatory Imaging Center
• 8.3. Hospital

9. Americas Diabetic Foot Ulcer Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Diabetic Foot Ulcer Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Diabetic Foot Ulcer Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Researchers develop 3D printed bandage that delivers innovative treatment for diabetic foot ulcers
  • 12.3.2. Healthium launches Theruptor Novo for diabetic foot ulcers
  • 12.3.3. Smith+Nephew announces new study showing GRAFIX Membrane cut the rate of diabetic foot ulcer recurrence in half compared to competitors
  • 12.3.4. Alkem Laboratories Announces Launch of Technology For Diabetic Foot Ulcer Management
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Adocia SA
• 3. Alkem Laboratories Ltd.
• 4. B. Braun SE
• 5. Cardinal Health, Inc.
• 6. Centaur Pharmaceuticals Private Limited
• 7. Cipla Limited
• 8. Coloplast Corp.
• 9. ConvaTec, Inc.
• 10. Essity AB
• 11. GlaxoSmithKline PLC
• 12. Healthium Medtech Limited
• 13. Integra LifeSciences Corporation
• 14. Medline Industries, Inc.
• 15. MIMEDX, Inc.
• 16. Molnlycke Health Care AB
• 17. Organogenesis, Inc.
• 18. PAUL HARTMANN AG
• 19. Pristyn Care
• 20. Reapplix A/S
• 21. SANUWAVE Health, Inc.
• 22. SIGVARIS Group
• 23. Smith & Nephew PLC
• 24. SynerHeal Pharmaceuticals
• 25. Tissue Regenix Ltd.
• 26. URGO Medical, Australia Pty Ltd.